


QUAMED asbl Revenue
Pharmaceutical Manufacturing • Brussels, Belgium • 11-20 Employees
QUAMED asbl revenue & valuation
| Annual revenue | $1,026,660 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $3,300,000 |
| Total funding | No funding |
Key Contacts at QUAMED asbl
Ed Vreeke
Executive Director
Daniel Berman
Vice President, Board Of Directors
Company overview
| Headquarters | Brussels, Belgium |
| Website | |
| NAICS | 3254 |
| SIC | 869 |
| Keywords | Supply Chain, Pharmaceutical, Consulting, Training, Quality, Audit, Quality Assurance, Worldwide, Procurement, Africa, Certification, Quality Standards, Drugs, Middle East, Asia, Medicines, Labelization |
| Founded | 2010 |
| Employees | 11-20 |
| Socials |
QUAMED asbl Email Formats
QUAMED asbl uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@quamed.org), used 55.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@quamed.org | 55.6% |
{first name}.{last name} | john.doe@quamed.org | 44.4% |
About QUAMED asbl
QUAMED is a not-for-profit membership association. Our objective to increase access to quality medicines using pharmaceutical audits, training and advisory services. The global pharmaceutical market is characterized by the coexistence of multiple quality standards : where patients in rich, strictly regulated countries can generally rely on the efficiency, safety and intrinsic quality of the medicines available to them, a large majority of people in resource-limited countries are at risk of receiving or buying poor quality pharmaceuticals. WHY? Here some of the reasons: > LACK OF RESOURCES from regulatory authorities in low- and middle-income countries (LMICs) > GROWING COMPLEXITY AND GLOBALISATION of the pharmaceutical market the increasing pressure on prices to the detriment of a clear definition of the required quality standards > LIMITED AWARENESS of the problem among key stakeholders, including some of the largest donors > LACK OF PUBLIC AND TRANSPARENT INFORMATION about the quality of medicines > LACK OF POLITICAL will at national and international level. Although the problem posed by counterfeit medicines is the subject of a growing number of global initiatives, that of sub-standard drugs - the extent of which is very worrying in the LMICs - remains insufficiently taken into account. Sub-standard drugs, however, have at least as negative impact on vulnerable populations health as counterfeit drugs have. OUR STRATEGY THE DEVELOPPEMENT OF A NORTH/SOUTH NETWORK to facilitate the sharing of reliable information on the sources of medicines and ease the communication between key players in pharmaceutical procurement. STREAMLINE THE USE OF RESOURCES BY POOLING SKILLS as well as human and financial resources across the network. PROVIDE RECOGNISED EXPERTS in pharmaceuticals and quality assurance systems.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
QUAMED asbl has 7 employees across 4 departments.
Departments
Number of employees
Funding Data
QUAMED asbl has never raised funding before.
QUAMED asbl Tech Stack
Discover the technologies and tools that power QUAMED asbl's digital infrastructure, from frameworks to analytics platforms.
Performance
JavaScript libraries
Advertising
Font scripts
JavaScript libraries
Web servers
Miscellaneous
Programming languages
Blogs
Widgets
Analytics
Widgets
Frequently asked questions
4.8
40,000 users



